The CEA second-look trial: A randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer

BMJ Open

Volumn 4, Issue 5, 2014, Pages

  Treasure, Tom ^a   Monson, Kathryn ^b   Fiorentino, Francesca ^c   Russell, Christopher ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DEATH CERTIFICATE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SECOND LOOK SURGERY; ADENOCARCINOMA; BLOOD; COLORECTAL NEOPLASMS; MIDDLE AGED; SINGLE BLIND PROCEDURE; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; SINGLE-BLIND METHOD;

EID: 84901006116     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004385     Document Type: Article

References (45)

1. Northover J, Houghton J, Lennon T. CEA to detect recurrence of colon cancer [Letter]. JAMA 1994;272:31. (Pubitemid 24195440)
2. Doshi P, Dickersin K, Healy D, et al. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013;346:f2865.
3. Loder E, Godlee F, Barbour V, et al. Restoring the integrity of the clinical trial evidence base. BMJ 2013;346:f3601.
4. Gill PG, Morris PJ. The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg 1978;65:17-20.
5. Slaney G. Results of treatment of carcinoma of the colon and rectum. In: Irvine T, ed. Modern Trends in Surgery 3rd ed. London: Butterworths Group; 1971:69-89.
6. Welch JP, Donaldson GA. Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 1978;135:505-11. (Pubitemid 8336686)
7. Goligher JC. Surgery of the anus, colon and rectum. 4th ed. London: Bailliere Tindall, 1980.
8. Martin EW Jr, Cooperman M, King G, et al. A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer. Am J Surg 1979;137:167-9. (Pubitemid 9092104)
9. Cochrane JP, Williams JT, Faber RG, et al. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. BMJ 1980;280:593-5. (Pubitemid 10174712)
10. Ekman CA, Gustavson J, Henning A. Value of a follow-up study of recurrent carcinoma of the colon and rectum. Surg Gynecol Obstet 1977;145:895-7. (Pubitemid 8241896)
11. Bacon HE, Berkley JL. The rationale of re-resection for recurrent cancer of the colon and rectum. Dis Colon Rectum 1959;2:549-54.
12. Polk HC Jr, Spratt JS Jr. Recurrent colorectal carcinoma: detection, treatment, and other considerations. Surgery 1971;69:9-23.
13. Ellis H. Is a ' second look operation ' justified in suspected recurrences after abdominal cancer surgery? Br J Surg 1975;62:830-2.
14. Wangensteen O, Lewis F, Arhelger S, et al. An interim report upon the second look procedure for cancer of the stomach, colon, and rectum and for limited intraperitoneal carcinosis. Surg Gynecol Obstet 1954;99:257-67.
15. Martin EW Jr, Cooperman M, Carey LC, et al. Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res 1980;28:389-94. (Pubitemid 10116914)
16. Staab HJ, Anderer FA, Stumpf E, et al. Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma. J Surg Oncol 1978;10:273-82. (Pubitemid 8349376)
17. Nicholson JR, Aust JC. Rising carcinoembryonic antigen titers in colorectal carcinoma: an indication for the second-look procedure. Dis Colon Rectum 1978;21:163-4. (Pubitemid 8341908)
18. Mackay AM, Patel S, Carter S, et al. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. BMJ 1974;4:382-5.
19. Mach JP, Jaeger P, Bertholet MM, et al. Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet 1974;304:535-40.
20. Goldenberg DM (Chair). Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement. BMJ (Clin Res Ed) 1981;282:373-5. (Pubitemid 11173651)
21. Meeker WR Jr. The use and abuse of CEA test in clinical practice. Cancer 1978;41:854-62.
22. Moertel CG, Schutt AJ, Go VL. Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA 1978;239:1065-6. (Pubitemid 8290953)
23. Lennon T, Houghton J, Northover J. Post operative CEA monitoring and second-look surgery in colorectal cancer: trial results [Abstract]. Br J Cancer 1994;70(Suppl xxii):16.
24. Grunhagen D, Jones RP, Treasure T, et al. The history of adoption of hepatic resection for metastatic colorectal cancer: 1984-95. Crit Rev Oncol Hematol 2013;86:222-31.
25. Embun R, Fiorentino F, Treasure T, et al. Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open 2013;3:pii: e002787.
26. Treasure T, Utley M, Hunt I. When professional opinion is not enough: surgical resection of pulmonary metastases. BMJ 2007;334:831-2.
27. Fiorentino F, Treasure T. Pulmonary metastasectomy for colorectal cancer: making the case for a randomized controlled trial in the zone of uncertainty. J Thorac Cardiovasc Surg 2013;146:748-52.
28. Fiorentino F, Hunt I, Teoh K, et al. Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med 2010;103:60-6.
29. Fiorentino F, Vasilakis C, Treasure T. Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis. Br J Cancer 2011;104:1085-97.
30. Treasure T. Carcinoembryonic antigen: its place in decision making for pulmonary metastasectomy in colorectal cancer. J Thorac Oncol 2010;5(6 Suppl 2):S179-81.
31. Searle F, Lovesey AC, Roberts BA, et al. Radioimmunoassay methods for carcinoembryonic antigen. J Immunol Methods 1974;4:113-25.
32. Lewis JC, Keep PA. Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts. Br J Cancer 1981;44:381-7. (Pubitemid 11007277)
33. Keep PA, Leake BA, Rogers GT. Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid. Br J Cancer 1978;37:171-82. (Pubitemid 8281316)
34. Poston G, Guideline Development Group. Colorectal cancer: the diagnosis and management of colorectal cancer. National Institute for Health and Clinical Excellence, 2011 [cited & Oct 2012]. http://guidance.nice.org.uk/CG131/ Guidance/pdf/English
35. Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014;311:263-70.
36. NCEPOD (National Confidential Enquiry into Patient Outcome and Death. The Coroner's autopsy: do we deserve better? 2006. National Confidential Enquiry into Patient Outcome and Death.
37. Kraemer HC. Toward non-parametric and clinically meaningful moderators and mediators. Stat Med 2008;27:1679-92. (Pubitemid 351566090)
38. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2:349-60.
39. Horton R. From star signs to trial guidelines. Lancet 2000;355:1033-4. (Pubitemid 30162803)
40. Morris EJ, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010;97:1110-18.
41. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-504.
42. Treasure T, Leonard P. Pulmonary metastasectomy in colorectal cancer. Br J Surg 2013;100:1403-4.
43. Treasure T, Morton D. GRIST: Growing Recruitment in Interventional and Surgical Trials. J R Soc Med 2012;105:140-1.
44. Utley M, Treasure T, Linklater K, et al. Better out than in? The resection of pulmonary metastases from colorectal tumours. In: Xie X, Lorca F, Marcon E. eds. Operations research for health care engineering: proceedings of the 33rd international conference on operational research applied to health services. Saint-Etienne: Publications de l'Universitaire de Saint-Etienne, 2008:493-500.
45. Levesque LE, Hanley JA, Kezouh A, et al. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010;340:b5087.